 WEST CHESTER, Pa., March 29, 2021 GLOBE NEWSWIRE -- Verrica Pharmaceuticals Inc. Verrica NASDAQ: VRCA, a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Gary Goldenberg, M.D., Verricas Chief Medical Officer, has been elected as an active member into the American Dermatological Association ADA. 